Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide (Bydureon) + Lifestyle Intervention in Adolescents with Obesity
NCT02794402Phase 2Completed
- Sponsor
- Uppsala University
- Start
- Sep 2015
- Primary completion
- Sep 2016
- Modality
- Peptides
- Countries
- 2
01
Overview
A Phase 2 trial of exenatide in obesity, sponsored by Uppsala University. Started Sep 2015; status: completed.
02
Drugs
exenatide
03
Conditions
obesity
Beyond the preview
Go deeper on NCT02794402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02794402.